[ASAP] Cyclic Ruthenium-Peptide Conjugates as Integrin-Targeting Phototherapeutic Prodrugs for the Treatment of Brain Tumors 🔗 Access full article via Journal of the American Chemical SocietyShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
